Swedish Palliative Care Guide (S-PCG) at Residential Facilities

Death Clinical Trial

Official title:

Swedish Palliative Care Guide (S-PCG) at Residential Facilities

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT06431659
• Other study ID #: 2023-02274-01-1
• Status: Enrolling by invitation
• Start date: May 20, 2024
• Est. completion date: May 3, 2027

Study information

• Verified date: May 2024
• Source: Region Skane
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Palliative care aims to improve the quality of life for patients and families who are affected life-threatening, incurable disease. The care should be person-centred, but it is not entirely clear how this is best achieved. The Institute for Palliative Care, Lund, has developed the Swedish Palliative Care Guide (S-PCG) which support for a person-centred approach throughout the palliative care process. The aim of this study is to implement the Swedish Palliative Care Guide (S-PCG) part 2 at Residential Facilities and evaluate functionality, effect and patient benefit in clinical use.

Description:

The concept of palliative care has changed over time and is not longer reserved for patients in the dying phase, on the contrary more and more studies show that early integration of palliative care and disease-specific care produce positive results. Specifically, palliative care is about prevent and alleviate suffering by early detection of symptoms and treatment of physical, psychological, social and existential problems. In order to provide the best care, a holistic approach is required that takes up what is important right now and not focus on individual diagnoses. The Swedish Palliative Care Guide (S-PCG) aims to support for a person-centred approach throughout the palliative care process. The purpose of S-PCG is to provide increased security and quality of life for patients and their relatives by identifying needs, make sure that these are addressed and followed up. S-PCG can be used cross-professionally and provides support for coordination and communication in care transitions, regardless of diagnosis or form of care. The research questions for this study are: 1. Has people living at Residential Facilities to a greater extent treatment restrictions, a stated plan in case of deterioration and information to relatives documented in the medical record after S-PCG was implemented compared to people who were cared for, at the same Residential Facilities, before S-PCG was implemented? 2. Do patients cared for after S-PCG was implemented feel more involved in decisions about their care and do they feel more safe to discuss their thoughts about the end of life (if they so wish)?

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 300
• Est. completion date: May 3, 2027
• Est. primary completion date: May 3, 2026
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years to 130 Years

Eligibility

Inclusion Criteria:

• Patients living in residential facilities.
• Ability to answer a short survey in Swedish.

Exclusion Criteria:

• Patients with dementia or other Cognitive Dysfunction.

Related Conditions & MeSH terms

• Age Problem
• Death
• Frailty
• Old Age; Debility

Locations

Country	Name	City	State
Sweden	Valgossens äldreboende	Stockholm	Region Stockholm

Sponsors (1)

Lead Sponsor	Collaborator
Region Skane

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Experience of security	Measured by likert scale, 1-5. Higher number indicate higher experience of security	baseline and 12 weeks after implementation of S-PCG
Primary	Experience of participation	Measured by likert scale, 1-5. Higher number indicate higher experience of participation	baseline and 12 weeks after implementation of S-PCG
Secondary	Breakpoint conversation	Presence of documented break point conversations in medical records.	baseline and 12 weeks after implementation of S-PCG
Secondary	Treatment limitations	Presence of documented treatment limitations in medical records.	baseline and 12 weeks after implementation of S-PCG